Replies to post #45485 on Biotech Values

[10nisman]

MNOV

Anyone have any thoughts/comments on MNOV?

TIA,
10nis

[nuere]

OXGN
I’m going to go out on a limb and predict that this quadruplet regimen (Avastin + CA4P + dual chemo) will prove to be too toxic, and that such a regimen will never be used commercially. Regards, Dew

With the proper dosing schedule I think this combination is possible. Kerbel has done some preclinical work (Science sep 06)that probably will form the basis for this scheduling.
Regards
nuere

[jbog]

Dew,

I'm not that familar with the toxic effect of CA4P, but as a example Bev plus Tarceva alone in lung is more effective than Bev/Tarceva/Doublet Chemo.

Bev seems to take the effect to the limit.

[onco]

to toxic. to expensive. i do this for a living. i know